
AI & Health · September 21, 2026
FDA Reviewers Flag No Major Concerns With Grail’s Multi-Cancer Test: Risk, Power and Accountability
Risk, Power and Accountability: what today’s cancer screening development means for AI, the evidence that matters, the risks, and the decisions leaders should make next.
9 min read





















